Table 2.
Characteristics of all included HIV-1 patients and patients included in the years 2002 to 2005 and 2006 to 2007
| Characteristics | Categories | Total | 2002-2005 | 2006-2007 |
|---|---|---|---|---|
|
Patients |
|
4317 |
2687 |
1630 |
|
Continent of origin, no (%) |
Western Europe |
2404 (56) |
1608 (60) |
796 (49) |
| Eastern Europe & Central Asia |
919 (21) |
424 (16) |
495 (30) |
|
| Sub-Saharan Africa |
472 (11) |
323 (12) |
149 (9) |
|
| Other |
354 (8) |
190 (7) |
164 (10) |
|
| Unknown |
168 (4) |
142 (5) |
26 (2) |
|
|
Gender, no. (%) |
Male |
3411 (79) |
2080 (77) |
1331 (82) |
|
Risk group, no. (%) |
MSM |
2084 (48) |
1230 (46) |
854 (52) |
| Hetero |
1501 (35) |
1004 (37) |
497 (30) |
|
| Injecting drug use |
355 (8) |
208 (8) |
147 (9) |
|
| Unknown |
377 (9) |
245 (9) |
132 (8) |
|
|
Subtype, no. (%) |
B |
2855 (66) |
1777 (66) |
1078 (66) |
| non-B |
1381 (32) |
849 (32) |
532 (33) |
|
| Unknown |
81 (2) |
61 (2) |
20 (1) |
|
|
Duration of infection, no (%) |
<1 year |
1236 (29) |
724 (27) |
512 (31) |
| 1-2 years |
144 (3) |
77 (3) |
67 (4) |
|
| Unknown |
2937 (68) |
1886 (70) |
1051 (64) |
|
| Plasma HIV-RNA, median (IQR), log copies/ml |
4.9 (4.3-5.3) |
4.9 (4.3-5.3) |
4.8 (4.2-5.4) |
|
| CD4 cell count, median (IQR), cells/mm3 |
352 (180–540) |
343 (163–533) |
370 (210–548) |
|
| Age, median years (IQR) | 35 (29–42) | 35 (29–42) | 35 (29–42) | |